Australia markets closed

Biotage AB (publ) (0GRP.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
220.40+3.81 (+1.76%)
As of 08:13AM BST. Market open.

Biotage AB (publ)

Vimpelgatan 5
Box 8
Uppsala 751 03
Sweden
46 18 56 59 00
https://www.biotage.com

Sector(s)
Industry
Full-time employees674

Key executives

NameTitlePayExercisedYear born
Mr. Torben Jorgensen B.Sc.CEO, President & Director857kN/A1952
Mr. Andrew KellettChief Financial OfficerN/AN/A1969
Mr. Anders Wikstrom BSc, CSExecutive Vice President of OperationsN/AN/A1973
Raffaella BombardaEVP of Global MarketingN/AN/A1974
Ms. Petra DuprezChief Human Resources & Sustainability OfficerN/AN/A1965
Mr. Scott CarrPresident of Americas & Chief/Head of AmericasN/AN/A1967
Mr. Jonas StahlbergChief AuditorN/AN/A1975
Mr. Olof NordExecutive Vice President of Business DevelopmentN/AN/A1975
Mr. Andreas JuhlinPresident of International - EMEA and APACN/AN/A1974
Mr. Magnus NordstedtExecutive Vice President of IT & DigitalizationN/AN/A1970
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Corporate governance

Biotage AB (publ)’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 8; Board: 9; Shareholder rights: 8; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.